中国
癌症
医学
心理健康
行动号召
动作(物理)
精神科
梅德林
心理学
内科学
政治学
量子力学
物理
业务
营销
法学
作者
Qiao Chu,Io Hong Cheong,PhuongThao D. Le,Lawrence H. Yang,Hui Wang,Brian J. Hall
标识
DOI:10.1016/s2215-0366(21)00180-2
摘要
Despite advances in cancer prevention and control strategies in the past few decades, the cancer burden remains high in China, with years of life lost per 100 000 population ranging from 541 to 1065 for stomach, liver, and lung cancers in 2017. 1 Zhou M Wang H Zeng X et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394: 1145-1158 Summary Full Text Full Text PDF PubMed Scopus (831) Google Scholar According to the GLOBOCAN 2020 online database, cancer in China comprised approximately 24% of new cases and 30% of cancer deaths worldwide in 2020.
科研通智能强力驱动
Strongly Powered by AbleSci AI